Ambien cr and Xarelto drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ambien cr and Xarelto. Common interactions include fall among females and arthritis bacterial among males.

The phase IV clinical study analyzes what interactions people who take Ambien cr and Xarelto have. It is created by eHealthMe based on reports of 23 people who take Ambien cr and Xarelto from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

23 people who take Ambien cr and Xarelto together, and have interactions are studied.


What is Ambien cr?

Ambien cr has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 5,428 Ambien cr users for its effectiveness, alternative drugs and more.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 196,974 Xarelto users for its effectiveness, alternative drugs and more.

Number of Ambien cr and Xarelto reports submitted per year:

Ambien cr and Xarelto drug interactions.

Common Ambien Cr and Xarelto drug interactions by gender *:

female:

  1. Fall
  2. Diarrhoea
  3. Hip fracture
  4. Hypertension
  5. Migraine
  6. Protein urine
  7. Hypersensitivity
  8. Arterial injury
  9. Asthenia
  10. Blood cholesterol increased

male:

  1. Arthritis bacterial
  2. Gingival bleeding
  3. Dysgeusia
  4. Fatigue
  5. Hypercholesterolaemia
  6. International normalised ratio increased
  7. Lung adenocarcinoma metastatic
  8. Malignant neoplasm progression
  9. Metastases to bone
  10. Metastases to central nervous system

Common Ambien Cr and Xarelto drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arterial injury
  2. Pre-existing condition improved
  3. Restless legs syndrome
  4. Therapeutic response unexpected

50-59:

  1. Arthritis bacterial
  2. Surgery

60+:

  1. Gingival bleeding
  2. Asthenia
  3. Drug ineffective
  4. Dry skin
  5. Dysgeusia
  6. Fall
  7. Fatigue
  8. Haemarthrosis
  9. Hypercholesterolaemia
  10. International normalised ratio increased

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 30.43%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 13.04%
  3. Sleep Disorder: 3 people, 13.04%
  4. Drowsiness: 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Ambien cr and Xarelto?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Ambien cr and Xarelto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ambien cr interactions:

Browse all interactions between Ambien cr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xarelto interactions:

Browse all interactions between Xarelto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate and rivaroxaban (the active ingredients of Ambien cr and Xarelto, respectively), and Ambien cr and Xarelto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ambien cr and Xarelto.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: